title: IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis.
abstract: Receptor endocytosis is critical for cell signaling. IGF1R mediates an autocrine loop that is de-regulated in Ewing Sarcoma (ES) cells. Here we study the impact of IGF1R internalization, mediated by clathrin and caveolin-1 (CAV1), in ES signaling. We used clathrin and CAV1-siRNA to interfere in clathrin- and caveolin-dependent endocytosis. Chlorpromazine (CPMZ) and methyl-beta-cyclo-dextrin (MCD) were also used in order to inhibit clathrin- and caveolin-dependent endocytosis, respectively. We analyzed IGF1R internalization and co-localization with clathrin and CAV1 upon ligand binding, as well as the status of the IGF1R pathway, cellular proliferation, and the apoptosis of interfered and inhibited ES cells. We performed a high-throughput tyrosine kinase phosphorylation assay to analyze the effects of combining the IGF1R tyrosine kinase inhibitor AEW541 (AEW) with CPMZ or MCD on the intracellular phospho-proteome. We observed that IGF1R is internalized upon ligand binding in ES cells and that this process is dependent on clathrin or CAV1. The blockage of receptor internalization inhibited AKT and MAPK phosphorylation, reducing the proliferative rate of ES cells and increasing the levels of apoptosis. Combination of AEW with CPMZ or MCD largely enhanced these effects. CAV1 and clathrin endocytosis controls IGF1R internalization and signaling and has a profound impact on ES IGF1R-promoted survival signaling. We propose the combination of tyrosine-kinase inhibitors with endocytosis inhibitors as a new therapeutic approach to achieve a stronger degree of receptor inhibition in this, or other neoplasms dependent on IGF1R signaling.
authors: Laboratory 20-Molecular Pathology of Sarcomas Laboratory, Centro de Investigación del Cáncer-IBMCC, Universidad de Salamanca-CSIC, Salamanca, Spain.
authors: Ana Sofia
authors: AS
authors: Martins
authors: José Luis
authors: JL
authors: Ordóñez
authors: Ana Teresa
authors: AT
authors: Amaral
authors: Frans
authors: F
authors: Prins
authors: Giuseppe
authors: G
authors: Floris
authors: Maria
authors: M
authors: Debiec-Rychter
authors: Pancras C W
authors: PC
authors: Hogendoorn
authors: Enrique
authors: E
authors: de Alava
references: Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5172-5
references: 7685118
references: Curr Opin Cell Biol. 2000 Apr;12(2):204-10
references: 10712919
references: Acta Biochim Biophys Sin (Shanghai). 2008 Jun;40(6):497-504
references: 18535748
references: Traffic. 2007 May;8(5):462-70
references: 17376169
references: J Cell Physiol. 2006 Aug;208(2):354-62
references: 16619240
references: Cell Mol Biol Lett. 2007;12(4):556-72
references: 17588222
references: J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):485-98
references: 19034632
references: Diabetologia. 1994 Sep;37 Suppl 2:S117-24
references: 7821727
references: Cancer Res. 2006 Oct 15;66(20):9937-47
references: 17047056
references: J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):471-83
references: 19023648
references: J Biol Chem. 2007 Aug 3;282(31):22513-24
references: 17545147
references: J Cell Physiol. 2008 Oct;217(1):281-9
references: 18506777
references: J Biol Chem. 2001 Mar 30;276(13):9670-8
references: 11121405
references: Prostate. 2009 Jan 1;69(1):33-40
references: 18785179
references: Am J Physiol Lung Cell Mol Physiol. 2003 Dec;285(6):L1179-83
references: 14604847
references: J Biol Chem. 2003 Feb 21;278(8):5794-801
references: 12482878
references: Eur J Biochem. 1994 Jul 1;223(1):195-202
references: 8033892
references: Clin Cancer Res. 2005 May 1;11(9):3233-42
references: 15867218
references: Horm Metab Res. 2003 Nov-Dec;35(11-12):675-84
references: 14710346
references: J Cell Biol. 1993 Dec;123(5):1107-17
references: 8245121
references: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3532-40
references: 16740780
references: J Biol Chem. 1997 Dec 5;272(49):30822-7
references: 9388225
references: J Biol Chem. 1998 Feb 20;273(8):4672-80
references: 9468528
references: J Biol Chem. 2004 Feb 27;279(9):8038-46
references: 14660565
references: Genes Chromosomes Cancer. 2010 Jan;49(1):40-51
references: 19787792
references: Cancer Res. 2008 Jul 15;68(14):5669-77
references: 18632619
references: Int J Cancer. 1994 Nov 1;59(3):427-34
references: 7927953
references: Cell. 2001 Jul 13;106(1):1-4
references: 11461694
references: Expert Opin Ther Targets. 2008 May;12(5):589-603
references: 18410242
references: Endocrinology. 1993 Apr;132(4):1421-30
references: 8384986
references: J Biol Chem. 1997 Dec 5;272(49):31051-7
references: 9388255
references: J Surg Oncol. 2007 Mar 1;95(3):183-4
references: 17323329
references: Endocrinology. 1988 May;122(5):2044-53
references: 2966062
references: Cancer Res. 2008 Aug 1;68(15):6260-70
references: 18676850
references: FASEB J. 2004 Dec;18(15):1801-11
references: 15576483
references: Cancer Res. 2009 Jan 1;69(1):161-70
references: 19117999
references: Endocrinology. 1994 Feb;134(2):744-50
references: 8299569